logo
[breadcrumb_custom]

Tag: NASDAQ:CBAY

ZM Stock
Finance

CBAY’s Stock Market Puzzle: Piecing Together 2023’s Performance

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price increase of 37.53%. However, over the past six months, we’ve seen a weaker performance of 121.89%. The price of CBAY fallen by 0.92% over the last 30 days. And in the last five days, it has surged by 0.05%. Cymabay Therapeutics Inc’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $32.49 on 03/21/24, with the lowest value being $7.26

Industry

Cymabay Therapeutics Inc (CBAY) Stock: Navigating Drops and Gains

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Cymabay Therapeutics Inc’s current trading price is 0.28% away from its 52-week high, while its distance from the 52-week low is 346.78%. The stock’s price range for this time frame has been between $7.26 and $32.35. The trading volume of the company’s shares in the Healthcare reached around 6.11 million for the day, which was evidently higher than the average daily volume of 3.68 million over the last three months. The market performance of Cymabay Therapeutics Inc has been

HCCC Stock
News

Cymabay Therapeutics Inc (CBAY) Stock: 52-Week Performance Insights and Trading Volume

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Cymabay Therapeutics Inc’s current trading price is -0.11% away from its 52-week high, while its distance from the 52-week low is 345.06%. The stock’s price range for this period has been between $7.26 and $32.35 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.98 million for the day, a number notably lower than the average daily volume of 3.68 million over the last three months. In terms of market performance, Cymabay Therapeutics

Stock

Analyzing the Impact of Earnings Reports on Cymabay Therapeutics Inc Inc. (CBAY) Price Performance

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a gain of 36.62%.However, over the last six months, we can see a weaker performance of 133.67%. Over the last 30 days, the price of CBAY has fallen by 35.93%. And in the last five days, it has surged by 0.25%. Cymabay Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $32.33 on 02/28/24, while the lowest

Finance

CBAY Stock: Exploring Cymabay Therapeutics Inc’s Growth

Cymabay Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $32.24 on 02/12/24, while the lowest price for the same period was registered at $7.26 on 06/27/23. 52-week price history of CBAY Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Cymabay Therapeutics Inc’s current trading price is -0.23% away from its 52-week high, while its distance from the 52-week low is 342.99%. The stock’s price range during this period has spanned from $7.26 to $32.24. In the Healthcare sector, the

ELVT Stock
Stock

Cymabay Therapeutics Inc (CBAY) Stock: Navigating a Year of Volatility

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Cymabay Therapeutics Inc’s current trading price is 21.94% away from its 52-week high, while its distance from the 52-week low is 342.51%. The stock’s price range for this period has been between $7.26 and $26.35 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 56.41 million for the day, a number notably higher than the average daily volume of 65.04 over the last three months. Cymabay Therapeutics Inc ‘s stock market performance has

OPEN Stock
Industry

CBAY’s Stock Market Adventure: 5.12% YTD Growth Amidst Volatility

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price gain of 5.12% this year. Over the last six months, there has been a weaker performance of 96.60%. The price of CBAY fallen by 1.55% during the last 30 days period. For the last 5-days stocks have improved 1.80%. Cymabay Therapeutics Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $25.37 on 02/08/24,

Stock

Cymabay Therapeutics Inc (CBAY) Stock: A Year of Market Fluctuations

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Cymabay Therapeutics Inc’s current trading price is -11.48% away from its 52-week high, while its distance from the 52-week low is 209.33%. The stock’s price range for this period has been between $7.26 and $25.37 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.81 million for the day, a number notably lower than the average daily volume of 1.88 million over the last three months. Cymabay Therapeutics Inc’s market performance has been